{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:51:47Z","timestamp":1790812307511,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":500,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1074\/mcp.ra119.001390","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T14:54:17Z","timestamp":1550760857000},"page":"936a-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia*"],"prefix":"10.1016","volume":"18","author":[{"given":"Lukas","family":"Janker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert L.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bileck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna C.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Utpatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Heudobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine","family":"Agis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Slany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.RA119.001390_bib1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"key":"10.1074\/mcp.RA119.001390_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clml.2018.02.015","article-title":"Multiple myeloma: clinical updates from the American Society of Hematology Annual Meeting, 2017","volume":"18","author":"Terpos","year":"2018","journal-title":"Cl. Lymph. Myelom. Leuk"},{"key":"10.1074\/mcp.RA119.001390_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2016.70.6705","article-title":"Genomics of multiple myeloma","volume":"35","author":"du Pont","year":"2017","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.RA119.001390_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/ijlh.12504","article-title":"Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"38","author":"van de Donk","year":"2016","journal-title":"Int. J. Lab. Hematol"},{"key":"10.1074\/mcp.RA119.001390_bib5","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone (s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"key":"10.1074\/mcp.RA119.001390_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","article-title":"Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability","volume":"33","author":"Dutta","year":"2018","journal-title":"Leukemia"},{"key":"10.1074\/mcp.RA119.001390_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejca.2005.12.025","article-title":"The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions","volume":"42","author":"Mitsiades","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1021\/pr400881p","article-title":"Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma","volume":"13","author":"Slany","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA119.001390_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coph.2016.02.013","article-title":"New approaches to targeting the bone marrow microenvironment in multiple myeloma","volume":"28","author":"Gooding","year":"2016","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1074\/mcp.RA119.001390_bib10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2017.01444","article-title":"Restoring natural killer cell immunity against multiple myeloma in the era of new drugs","volume":"8","author":"Pittari","year":"2017","journal-title":"Front. Immunol"},{"key":"10.1074\/mcp.RA119.001390_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1242\/dmm.008961","article-title":"Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models","volume":"5","author":"Hu","year":"2012","journal-title":"Dis. Model Mech"},{"key":"10.1074\/mcp.RA119.001390_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000488423","article-title":"Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells","volume":"46","author":"Filippi","year":"2018","journal-title":"Cell Physiol. Biochem"},{"key":"10.1074\/mcp.RA119.001390_bib13","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/leu.2010.193","article-title":"Low bone marrow oxygen tension and hypoxia-inducible factor-1 alpha overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells","volume":"24","author":"Colla","year":"2010","journal-title":"Leukemia"},{"key":"10.1074\/mcp.RA119.001390_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/leu.2011.122","article-title":"The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma","volume":"25","author":"Martin","year":"2011","journal-title":"Leukemia"},{"key":"10.1074\/mcp.RA119.001390_bib15","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/blood-2003-04-1338","article-title":"Endothelial cells in the bone marrow of patients with multiple myeloma","volume":"102","author":"Vacca","year":"2003","journal-title":"Blood"},{"key":"10.1074\/mcp.RA119.001390_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cas.13183","article-title":"Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma","volume":"108","author":"Ikeda","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1074\/mcp.RA119.001390_bib17","first-page":"706","article-title":"Hypoxia inducible factor-1 alpha and multiple myeloma","volume":"4","author":"Bhaskar","year":"2016","journal-title":"Int. J. Adv. Res"},{"key":"10.1074\/mcp.RA119.001390_bib18","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1021\/pr500727h","article-title":"Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts","volume":"13","author":"Groessl","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA119.001390_bib19","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1074\/mcp.M116.058099","article-title":"Contribution of human fibroblasts and endothelial cells to the hallmarks of inflammation as determined by proteome profiling","volume":"15","author":"Slany","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001390_bib20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/acs.analchem.6b04433","article-title":"Combined proteome and eicosanoid profiling approach for revealing implications of human fibroblasts in chronic inflammation","volume":"89","author":"Tahir","year":"2017","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.RA119.001390_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1074\/mcp.M116.063313","article-title":"Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma","volume":"16","author":"Muqaku","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001390_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1074\/mcp.RA117.000425","article-title":"Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia","volume":"17","author":"Mayer","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001390_bib23","doi-asserted-by":"crossref","first-page":"56726","DOI":"10.18632\/oncotarget.11059","article-title":"Comparative proteomic profiling of refractory\/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy","volume":"7","author":"Dytfeld","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA119.001390_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.18632\/genesandcancer.88","article-title":"Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets","volume":"6","author":"Fernando","year":"2015","journal-title":"Genes Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.18632\/oncotarget.1049","article-title":"Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma","volume":"4","author":"Xie","year":"2013","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA119.001390_bib26","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jprot.2010.03.004","article-title":"Phosphoproteomic analysis of primary human multiple myeloma cells","volume":"73","author":"Ge","year":"2010","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.RA119.001390_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jprot.2012.07.012","article-title":"Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells","volume":"76","author":"Haudek-Prinz","year":"2012","journal-title":"J Proteomics"},{"key":"10.1074\/mcp.RA119.001390_bib28","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1021\/pr5008625","article-title":"Comprehensive Assessment of Proteins Regulated by Dexamethasone Reveals Novel Effects in Primary Human Peripheral Blood Mononuclear Cells","volume":"13","author":"Bileck","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA119.001390_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.RA119.001390_bib30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.RA119.001390_bib31","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizcaino","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA119.001390_bib32","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: A report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.RA119.001390_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-13-S16-S12","article-title":"1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data","volume":"13","author":"Cox","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1074\/mcp.RA119.001390_bib34","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1093\/nar\/gki624","article-title":"oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes","volume":"33","author":"Ho Sui","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA119.001390_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2141.1988.00321.x-i1","article-title":"Establishment and characterization of a permanent human Iga2 kappa-myeloma cell-line","volume":"69","author":"Lohmeyer","year":"1988","journal-title":"Brit. J. Haematol"},{"key":"10.1074\/mcp.RA119.001390_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2141.1997.72653.x","article-title":"Circulating plasma cells in multiple myeloma: Characterization and correlation with disease stage","volume":"97","author":"Rawstron","year":"1997","journal-title":"Brit. J. Haematol"},{"key":"10.1074\/mcp.RA119.001390_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1074\/mcp.RA119.001390_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc"},{"key":"10.1074\/mcp.RA119.001390_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA119.001390_bib40","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"UniProt: the universal protein knowledgebase","volume":"45","author":"Bateman","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA119.001390_bib41","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1089\/ars.2009.2501","article-title":"Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species","volume":"11","author":"Shimizu","year":"2009","journal-title":"Antioxid. Redox Sign"},{"key":"10.1074\/mcp.RA119.001390_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-013-1433-1","article-title":"Expression of peroxiredoxins I and IV in multiple myeloma: association with immunoglobulin accumulation","volume":"463","author":"Demasi","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1074\/mcp.RA119.001390_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1081208","article-title":"BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis","volume":"300","author":"Scorrano","year":"2003","journal-title":"Science"},{"key":"10.1074\/mcp.RA119.001390_bib44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2015.03.064","article-title":"IRE1 alpha-TRAF2-ASK1 complex-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to CXC195-induced apoptosis in human bladder carcinoma T24 cells","volume":"460","author":"Zeng","year":"2015","journal-title":"Biochem. Bioph. Res. Co"},{"key":"10.1074\/mcp.RA119.001390_bib45","doi-asserted-by":"crossref","first-page":"e15636","DOI":"10.1371\/journal.pone.0015636","article-title":"Praf2 is a novel Bcl-xL\/Bcl-2 interacting protein with the ability to modulate survival of cancer cells","volume":"2010","author":"Vento","year":"2010","journal-title":"Plos One"},{"key":"10.1074\/mcp.RA119.001390_bib46","first-page":"1962","article-title":"SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic beta-cells","volume":"126","author":"Tiwari","year":"2013","journal-title":"J. Cell Sci"},{"key":"10.1074\/mcp.RA119.001390_bib47","doi-asserted-by":"crossref","first-page":"e1219","DOI":"10.1038\/cddis.2014.193","article-title":"Cab45S inhibits the ER stress-induced IRE1-JNK pathway and apoptosis via GRP78\/BiP","volume":"5","author":"Chen","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1074\/mcp.RA119.001390_bib48","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1038\/oncsis.2017.6","article-title":"RCN1 suppresses ER stress-induced apoptosis via calcium homeostasis and PERK-CHOP signaling","volume":"6","author":"Xu","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1074\/mcp.RA119.001390_bib49","first-page":"4767","article-title":"Cetuximab enhances cisplatin-induced endoplasmic reticulum stress-associated apoptosis in laryngeal squamous cell carcinoma cells by inhibiting expression of TXNDC5","volume":"17","author":"Peng","year":"2018","journal-title":"Mol. Med. Reports"},{"key":"10.1074\/mcp.RA119.001390_bib50","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Gene Dev"},{"key":"10.1074\/mcp.RA119.001390_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1074\/mcp.RA119.001390_bib52","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2007-11-120576","article-title":"Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1","volume":"111","author":"Shin","year":"2008","journal-title":"Blood"},{"key":"10.1074\/mcp.RA119.001390_bib53","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1101\/gad.924501","article-title":"FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity","volume":"15","author":"Mahon","year":"2001","journal-title":"Genes Dev"},{"key":"10.1074\/mcp.RA119.001390_bib54","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-12-1383","article-title":"Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells","volume":"72","author":"Noman","year":"2012","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.RA119.001390_bib55","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.18632\/oncotarget.2593","article-title":"Hypoxia-inducible factors enhance glutamate signaling in cancer cells","volume":"5","author":"Hu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA119.001390_bib56","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1011777108","article-title":"VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration","volume":"108","author":"Razorenova","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001390_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15407\/ubj88.06.052","article-title":"Hypoxic regulation of MYBL1, MEST, TCF3, TCF8, GTF2B, GTF2F2 and SNAI2 genes expression in U87 glioma cells upon IRE1 inhibition","volume":"88","author":"Minchenko","year":"2016","journal-title":"Ukr. Biochem. J"},{"key":"10.1074\/mcp.RA119.001390_bib58","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1172\/JCI85856","article-title":"Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells","volume":"126","author":"Sherbenou","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1074\/mcp.RA119.001390_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4049\/jimmunol.1500257","article-title":"Monocyte stabilin-1 suppresses the activation of Th1 lymphocytes","volume":"196","author":"Palani","year":"2016","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.RA119.001390_bib60","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1158\/1078-0432.CCR-14-1236","article-title":"Clever-1\/stabilin-1 controls cancer growth and metastasis","volume":"20","author":"Karikoski","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1074\/mcp.RA119.001390_bib61","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1080\/10428194.2017.1295142","article-title":"The inhibitory receptor toll interleukin-1R 8 (TIR8\/IL-1R8\/SIGIRR) is downregulated in chronic lymphocytic leukemia","volume":"58","author":"Vilia","year":"2017","journal-title":"Leukemia Lymphoma"},{"key":"10.1074\/mcp.RA119.001390_bib62","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.4049\/jimmunol.0904176","article-title":"Bam32\/DAPP1 promotes B cell adhesion and formation of polarized conjugates with T cells","volume":"184","author":"Al-Alwan","year":"2010","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.RA119.001390_bib63","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.RA119.001390_bib64","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"10.1074\/mcp.RA119.001390_bib65","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.18632\/oncotarget.3237","article-title":"Drug metabolism and clearance system in tumor cells of patients with multiple myeloma","volume":"6","author":"Hassen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA119.001390_bib66","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1038\/onc.2017.79","article-title":"PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4","volume":"36","author":"Ueno","year":"2017","journal-title":"Oncogene"},{"key":"10.1074\/mcp.RA119.001390_bib67","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3324\/haematol.2012.066944","article-title":"Kruppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma","volume":"98","author":"Schoenhals","year":"2013","journal-title":"Haematologica"},{"key":"10.1074\/mcp.RA119.001390_bib68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2006.02.003","article-title":"Loss of Pax5 promotes plasma cell differentiation","volume":"24","author":"Nera","year":"2006","journal-title":"Immunity"},{"key":"10.1074\/mcp.RA119.001390_bib69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12185-010-0691-9","article-title":"Overexpression of PAX5 induces apoptosis in multiple myeloma cells","volume":"92","author":"Proulx","year":"2010","journal-title":"Int. J. Hematol"},{"key":"10.1074\/mcp.RA119.001390_bib70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.RA119.001390_bib71","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1073\/pnas.1212904110","article-title":"GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001390_bib72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ng.2350","article-title":"The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.RA119.001390_bib73","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V99.1.394","article-title":"Oxygen saturation in the bone marrow of healthy volunteers","volume":"99","author":"Harrison","year":"2002","journal-title":"Blood"},{"key":"10.1074\/mcp.RA119.001390_bib74","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/mp200279p","article-title":"Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma","volume":"8","author":"Silva","year":"2011","journal-title":"Mol. Pharm"},{"key":"10.1074\/mcp.RA119.001390_bib75","doi-asserted-by":"crossref","first-page":"9948","DOI":"10.1073\/pnas.1705338114","article-title":"Glucocorticoids promote Von Hippel Lindau degradation and Hif-1alpha stabilization","volume":"114","author":"Vettori","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001390_bib76","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tibs.2009.03.006","article-title":"IF(1): setting the pace of the F(1)F(o)-ATP synthase","volume":"34","author":"Campanella","year":"2009","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/mcp.RA119.001390_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2008.06.001","article-title":"Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1","volume":"8","author":"Campanella","year":"2008","journal-title":"Cell Metab"},{"key":"10.1074\/mcp.RA119.001390_bib78","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbamcr.2011.08.007","article-title":"TRAP-1, the mitochondrial Hsp90","volume":"1823","author":"Altieri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/mcp.RA119.001390_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/genes9040195","article-title":"TRAP1 regulation of cancer metabolism: dual role as oncogene or tumor suppressor","volume":"9","author":"Matassa","year":"2018","journal-title":"Genes"},{"key":"10.1074\/mcp.RA119.001390_bib80","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/ncomms3139","article-title":"Landscape of the mitochondrial Hsp90 metabolome in tumours","volume":"4","author":"Chae","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1074\/mcp.RA119.001390_bib81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature25460","article-title":"Mitochondrial translation requires folate-dependent tRNA methylation","volume":"554","author":"Morscher","year":"2018","journal-title":"Nature"},{"key":"10.1074\/mcp.RA119.001390_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-76","article-title":"Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress","volume":"14","author":"Goto","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/bjc.2012.527","article-title":"PDK1 inhibition is a novel therapeutic target in multiple myeloma","volume":"108","author":"Fujiwara","year":"2013","journal-title":"Brit. J. Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib85","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2941-6","article-title":"MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib86","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Molecular Cell"},{"key":"10.1074\/mcp.RA119.001390_bib87","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1038\/bcj.2014.82","article-title":"Hypoxia promotes stem cell-like phenotype in multiple myeloma cells","volume":"4","author":"Muz","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1074\/mcp.RA119.001390_bib88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-01-690743","article-title":"Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target","volume":"128","author":"Bolzoni","year":"2016","journal-title":"Blood"},{"key":"10.1074\/mcp.RA119.001390_bib89","first-page":"247","article-title":"Aberrant glycosylation of Igg heavy chain in multiple myeloma","volume":"31","author":"Aurer","year":"2007","journal-title":"Coll. Antropol"},{"key":"10.1074\/mcp.RA119.001390_bib90","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1038\/ncomms11457","article-title":"Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor","volume":"7","author":"Krall","year":"2016","journal-title":"Nat. Commun"},{"key":"10.1074\/mcp.RA119.001390_bib91","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1073\/pnas.90.5.2060","article-title":"In vitro culture of primary plasmacytomas requires stromal cell feeder layers","volume":"90","author":"Degrassi","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001390_bib92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","article-title":"Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion","volume":"56","author":"Zhang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.RA119.001390_bib93","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cncr.11480","article-title":"A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma","volume":"98","author":"Agrawal","year":"2003","journal-title":"Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-017-0169-9","article-title":"Bortezomib resistance in multiple myeloma is associated with increased serine synthesis","volume":"5","author":"Zaal","year":"2017","journal-title":"Cancer Metab"},{"key":"10.1074\/mcp.RA119.001390_bib95","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1074\/jbc.R800068200","article-title":"Mitochondrial fatty acid synthesis type II: more than just fatty acids","volume":"284","author":"Hiltunen","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001390_bib96","first-page":"39","article-title":"Mitochondrial fatty acid synthesis, fatty acids and mitochondrial physiology","volume":"1862","author":"Kastaniotis","year":"2017","journal-title":"Bba-Mol. Cell. Biol. L"},{"key":"10.1074\/mcp.RA119.001390_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2015.12.021","article-title":"Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation","volume":"91","author":"Deepa","year":"2016","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/mcp.RA119.001390_bib98","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201308006","article-title":"The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission","volume":"204","author":"Anand","year":"2014","journal-title":"J. Cell Biol"},{"key":"10.1074\/mcp.RA119.001390_bib99","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ng.3354","article-title":"Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder","volume":"47","author":"Abrams","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.RA119.001390_bib100","first-page":"4954","article-title":"MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria","volume":"127","author":"Lee","year":"2014","journal-title":"J. Cell Sci"},{"key":"10.1074\/mcp.RA119.001390_bib101","article-title":"Diagnostic electron microscopy of tumours","author":"Ghadially","year":"1985","journal-title":"Butterworths"},{"key":"10.1074\/mcp.RA119.001390_bib102","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.celrep.2018.02.051","article-title":"An essential role for ECSIT in mitochondrial complex I assembly and mitophagy in macrophages","volume":"22","author":"Carneiro","year":"2018","journal-title":"Cell Rep"},{"key":"10.1074\/mcp.RA119.001390_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00277-011-1246-8","article-title":"Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells","volume":"91","author":"Tirado-Velez","year":"2012","journal-title":"Ann. Hematol"},{"key":"10.1074\/mcp.RA119.001390_bib104","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","journal-title":"Ann. Hematol"},{"key":"10.1074\/mcp.RA119.001390_bib105","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.18632\/oncotarget.6453","article-title":"NF-Y activates genes of metabolic pathways altered in cancer cells","volume":"7","author":"Benatti","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA119.001390_bib106","doi-asserted-by":"crossref","first-page":"e94543","DOI":"10.1172\/jci.insight.94543","article-title":"Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies","volume":"3","author":"Gonsalves","year":"2018","journal-title":"JCI Insight"},{"key":"10.1074\/mcp.RA119.001390_bib107","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/bbrc.2001.5427","article-title":"Heat shock proteins: endogenous modulators of apoptotic cell death","volume":"286","author":"Garrido","year":"2001","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA119.001390_bib108","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","article-title":"The glucose-regulated proteins: stress induction and clinical applications","volume":"26","author":"Lee","year":"2001","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/mcp.RA119.001390_bib109","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1074\/jbc.275.14.10388","article-title":"Up-regulation of protein-disulfide isomerase in response to hypoxia\/brain ischemia and its protective effect against apoptotic cell death","volume":"275","author":"Tanaka","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001390_bib110","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1158\/0008-5472.CAN-14-1017","article-title":"HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization","volume":"74","author":"Azoitei","year":"2014","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.RA119.001390_bib111","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.leukres.2006.04.001","article-title":"Aberrant DNA demethylation in promoter region and aberrant expression of mRNA of PAX4 gene in hematologic malignancies","volume":"30","author":"Li","year":"2006","journal-title":"Leukemia Res"},{"key":"10.1074\/mcp.RA119.001390_bib112","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-016-3864-0","article-title":"PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus","volume":"59","author":"Mellado-Gil","year":"2016","journal-title":"Diabetologia"},{"key":"10.1074\/mcp.RA119.001390_bib113","doi-asserted-by":"crossref","first-page":"483796","DOI":"10.1155\/2012\/483796","article-title":"Involvement of Src in the adaptation of cancer cells under microenvironmental stresses","volume":"2012","author":"Mahbub Hasan","year":"2012","journal-title":"J. Signal Transduct"},{"key":"10.1074\/mcp.RA119.001390_bib114","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1128\/MCB.21.22.7653-7662.2001","article-title":"Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis","volume":"21","author":"Eischen","year":"2001","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/mcp.RA119.001390_bib115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12253-008-9138-5","article-title":"PIG11 is involved in hepatocellular carcinogenesis and its over-expression promotes Hepg2 cell apoptosis","volume":"15","author":"Wu","year":"2009","journal-title":"Pathol. Oncol. Res"},{"key":"10.1074\/mcp.RA119.001390_bib116","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2346-6","article-title":"The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase","volume":"16","author":"Crivellaro","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.RA119.001390_bib117","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.3892\/mmr.2016.5790","article-title":"Hypoxia mediates osteocyte ORP150 expression and cell death in vitro","volume":"14","author":"Montesi","year":"2016","journal-title":"Mol. Med. Rep"},{"key":"10.1074\/mcp.RA119.001390_bib118","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1074\/jbc.M114.618611","article-title":"Targeted identification of sialoglycoproteins in hypoxic endothelial cells and validation in zebrafish reveal roles for proteins in angiogenesis","volume":"290","author":"Delcourt","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001390_bib119","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2007.08.028","article-title":"Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network","volume":"131","author":"Kang","year":"2007","journal-title":"Cell"},{"key":"10.1074\/mcp.RA119.001390_bib120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cellsig.2015.11.002","article-title":"Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1\/2 and AKT activation","volume":"28","author":"Winter","year":"2016","journal-title":"Cell Signal"},{"key":"10.1074\/mcp.RA119.001390_bib121","doi-asserted-by":"crossref","first-page":"11914","DOI":"10.1158\/0008-5472.CAN-07-1868","article-title":"Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.RA119.001390_bib122","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2013.02.017","article-title":"Control of autophagic cell death by caspase-10 in multiple myeloma","volume":"23","author":"Lamy","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1074\/mcp.RA119.001390_bib123","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/jjco\/hyy133","article-title":"Therapeutic antibodies for multiple myeloma","volume":"48","author":"Ishida","year":"2018","journal-title":"Jpn. J. Clin. Oncol"},{"key":"10.1074\/mcp.RA119.001390_bib124","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/MCB.20.15.5363-5369.2000","article-title":"Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions","volume":"20","author":"Knobeloch","year":"2000","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/mcp.RA119.001390_bib125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fimmu.2015.00653","article-title":"Function and dynamics of tetraspanins during antigen recognition and immunological synapse formation","volume":"6","author":"Rocha-Perugini","year":"2016","journal-title":"Front. Immunol"},{"key":"10.1074\/mcp.RA119.001390_bib126","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.4049\/jimmunol.1402382","article-title":"Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors","volume":"194","author":"God","year":"2015","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.RA119.001390_bib127","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620316042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620316042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.RA119.001390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:29:57Z","timestamp":1761524997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620316042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":127,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1535947620316042"],"URL":"https:\/\/doi.org\/10.1074\/mcp.ra119.001390","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia*","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.RA119.001390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Janker et al.","name":"copyright","label":"Copyright"}]}}